Cargando…
A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles
The rodent protoparvovirus H-1PV, with its oncolytic and oncosuppressive properties, is a promising anticancer agent currently under testing in clinical trials. This explains the current demand for a scalable, good manufacturing practice-compatible virus purification process yielding high-grade pure...
Autores principales: | Leuchs, Barbara, Frehtman, Veronika, Riese, Markus, Müller, Marcus, Rommelaere, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380694/ https://www.ncbi.nlm.nih.gov/pubmed/28091791 http://dx.doi.org/10.1007/s00253-016-8071-x |
Ejemplares similares
-
Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application
por: Frehtman, Veronika, et al.
Publicado: (2023) -
Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus
por: Wohlfarth, Daniel, et al.
Publicado: (2021) -
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022) -
Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks
por: Couto, Pedro Silva, et al.
Publicado: (2023) -
Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients
por: Angelova, Assia L., et al.
Publicado: (2015)